Nitric oxide synthases: targets for therapeutic strategies in neurological diseases

PE Chabrier, C Demerle-Pallardy, M Auguet - Cellular and Molecular Life …, 1999 - Springer
Glutamate excitotoxicity, oxidative stress, and mitochondrial dysfunctions are common
features leading to neuronal death in cerebral ischemia, traumatic brain injury, Parkinson's …

Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia.

…, S Eddahibi, P Braquet, PE Chabrier - The Journal of …, 1991 - Am Soc Clin Investig
To determine whether exposure to chronic hypoxia and subsequent development of pulmonary
hypertension induces alterations of endothelium-dependent relaxation in rat pulmonary …

Selective inhibition of inducible nitric oxide synthase by agmatine

…, I Viossat, JG Marin, PE Chabrier - The Japanese Journal of …, 1995 - jstage.jst.go.jp
… endothelium intact rings of rat aorta precontracted with PE, indicating a lack of interaction
of … , the loss of tonicity of the contractile response to PE that reflects activation of iNOS (11-14) …

Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models

C Favre-Guilmard, M Auguet, PE Chabrier - European journal of …, 2009 - Elsevier
In addition to inhibition of acetylcholine release in the neuromuscular junction botulinum
toxin type A (BoNT-A) also inhibits the release of mediators involved in pain perception. We …

BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy

PE Chabrier, M Auguet, B Spinnewyn… - Proceedings of the …, 1999 - National Acad Sciences
Nitric oxide (NO) and reactive oxygen species (ROS) act independently as well as cooperatively
to induce neuronal death in acute neurological disorders. Inhibition of neuronal nitric …

[HTML][HTML] Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors

…, F Yu, C Boone, S Palan, M Beard, PE Chabrier… - Nature …, 2017 - nature.com
Botulinum neurotoxin B is a Food and Drug Administration-approved therapeutic toxin.
However, it has lower binding affinity toward the human version of its major receptor, …

Phenolic thiazoles as novel orally-active neuroprotective agents

…, A Rolland, JG Marin, D Bigg, PE Chabrier - Bioorganic & medicinal …, 2004 - Elsevier
Novel phenolic thiazoles compounds were prepared which demonstrated potent antioxidant
activity and potent in vivo neuroprotection in mitochondrial toxin models and also possess …

[HTML][HTML] High-throughput 3D whole-brain quantitative histopathology in rodents

…, D Briet, D Carré, J Schulz, P Hantraye, PE Chabrier… - Scientific reports, 2016 - nature.com
Histology is the gold standard to unveil microscopic brain structures and pathological alterations
in humans and animal models of disease. However, due to tedious manual interventions…

Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease

…, G Gardian, S Browne, PE Chabrier… - Journal of …, 2003 - Wiley Online Library
There is substantial evidence that excitotoxicity and oxidative damage may contribute to
Huntington's disease (HD) pathogenesis. We examined whether the novel anti‐oxidant …

The arterial wall: a new pharmacological and therapeutic target

…, P Vanhoutte, I Cavero, PE Chabrier… - Fundamental & …, 1996 - Wiley Online Library
In recent years, two key concepts having numerous interrelationships were advanced for the
understanding of various cardiovascular diseases: the “endothelial dysfunction” and the “…